The CATH-VR study will investigate the effect of virtual reality (VR) on patient pain,
anxiety, and radial artery vasospasm during coronary angiography. Our hypothesis is that the
use of VR will decrease patient anxiety and pain via validated scoring systems, as well as
show a low rate of vasospasm of the radial artery. In addition, we hypothesize that the
amount of opioid and benzodiazepine medications utilized for procedural sedation will be
lower in the intervention arm. VR has gained recent attraction as an alternative or
adjunctive treatment option for pain, but its effect on reducing procedural sedation has not
been studied. We propose a single center, randomized control pilot study to further
investigate. The patient population will include adults older than 18 years who present for
outpatient diagnostic coronary angiography.